These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4298251)

  • 1. Susceptibility of mammary tissues of different strains of mice to tumor development.
    Dux A; Mühlbock O
    J Natl Cancer Inst; 1968 Jun; 40(6):1259-72. PubMed ID: 4298251
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors.
    Nandi S; Haslam S; Helmich C
    J Natl Cancer Inst; 1972 Apr; 48(4):1005-12. PubMed ID: 4336864
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
    Lavrin DH
    Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to small amounts of Bittner mammary tumor virus in offspring of C57BL female mice with the virus.
    Bentvelzen P
    J Natl Cancer Inst; 1968 Sep; 41(3):757-65. PubMed ID: 4300310
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW; Wagner KU; Hennighausen L
    Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of cancer in quantitatively transplanted mammary glands and its relation to age and milk agent of the donor and host mice.
    Hoshino K; Gardner WU; Pawlikowski RA
    Cancer Res; 1965 Nov; 25(10):1792-803. PubMed ID: 4285689
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
    Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary gland development after hypophysial isografts in intact mice of high and low mammary cancer strains.
    Bardin CW; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1966 Feb; 36(2):259-75. PubMed ID: 5948624
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
    Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
    Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic and bioassay studies of milk from mice of high and low mammary-cancer and high and low leukemia strains.
    Dmochowski L; Langford PL; Williams WC; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1968 Jun; 40(6):1339-58. PubMed ID: 4298257
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tumors, particularly mammary tumors, in agent-free substrain R3eB-De mice.
    Deringer MK
    J Natl Cancer Inst; 1969 Dec; 43(6):1347-51. PubMed ID: 4319252
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL; Goldman L; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract]   [Full Text] [Related]  

  • 15. Histopathology of transgenic mouse mammary tumors (a short atlas).
    Munn RJ; Webster M; Muller WJ; Cardiff RD
    Semin Cancer Biol; 1995 Jun; 6(3):153-8. PubMed ID: 7495983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3H-Avy--a high hepatoma and high mammary tumor strain of mice.
    Heston WE; Vlahakis G
    J Natl Cancer Inst; 1968 Jun; 40(6):1161-6. PubMed ID: 4298250
    [No Abstract]   [Full Text] [Related]  

  • 18. Propagation of the mammary tumor agent (Bittner virus) in the absence of mammary glands in mice.
    Dux A; Mühlbock O
    J Natl Cancer Inst; 1968 Jun; 40(6):1309-12. PubMed ID: 4298253
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenically distinct forms of mammary tumor virus in blood and mammary tissues of mice.
    Nandi S; Haslam S; Aldrich CD
    J Natl Cancer Inst; 1971 May; 46(5):1035-44. PubMed ID: 4333722
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on DDD mouse with special reference to mammary gland tumors.
    Matsuzawa A; Yamamoto T; Suzuki K
    Jpn J Exp Med; 1970 Jun; 40(3):159-81. PubMed ID: 4319726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.